ERADX Trademark

Trademark Overview


On Monday, June 6, 2022, a trademark application was filed for ERADX with the United States Patent and Trademark Office. The USPTO has given the ERADX trademark a serial number of 97443914. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2024. This trademark is owned by EPIEN Medical, Inc.. The ERADX trademark is filed in the Pharmaceutical Products category with the following description:

Topical liquid chemical preparations for medical and medical therapeutic use in eliminating bacteria and debris; topical liquid chemical medical preparations for application to oral cavities to treat infectious oral tissue; mouth cavity cleansers; medicated dental preparations for application to oral cavities prior to dental treatments to treat infectious oral tissue; medicated topical solution for removal of dental layer of microorganisms; bacteriostats for dental use; topical liquid chemical medical preparations to prevent and control infections of the oral cavity
eradx

General Information


Serial Number97443914
Word MarkERADX
Filing DateMonday, June 6, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements


Goods and ServicesTopical liquid chemical preparations for medical and medical therapeutic use in eliminating bacteria and debris; topical liquid chemical medical preparations for application to oral cavities to treat infectious oral tissue; mouth cavity cleansers; medicated dental preparations for application to oral cavities prior to dental treatments to treat infectious oral tissue; medicated topical solution for removal of dental layer of microorganisms; bacteriostats for dental use; topical liquid chemical medical preparations to prevent and control infections of the oral cavity

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEPIEN Medical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSt. Paul, MN 55110

Party NameEPIEN Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Paul, MN 55110

Trademark Events


Event DateEvent Description
Thursday, June 9, 2022NEW APPLICATION ENTERED
Tuesday, June 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Tuesday, February 7, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 7, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 1, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024SOU EXTENSION 1 FILED
Wednesday, January 17, 2024SOU EXTENSION 1 GRANTED